Cargando…
A short focus, azithromycin in the treatment of respiratory viral infection COVID-19: efficacy or inefficacy?
Azithromycin is a macrolide antibiotic. Recent evidence has demonstrated in vitro activity against a wide variety of respiratory tract viruses, including SARS-CoV-2 responsible for the current global pandemic COVID-19. A mechanism of action acting on different phases of the viral cycle is assumed. I...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570229/ https://www.ncbi.nlm.nih.gov/pubmed/34739696 http://dx.doi.org/10.1007/s12026-021-09244-x |